iPierian's Series A - II Round

iPierian raised a round of funding on July 22, 2009.

iPierian is a biotechnology company developing therapies for neurodegenerative disease, specifically focused on discovering monoclonal antibodies against targets of the Tau protein for treatment of Al…

Articles about iPierian's Series A - II Round: